SPOTLIGHT -
Expert perspectives on optimal treatment strategies for patients who develop steroid-refractory chronic graft-versus-host disease.
Quizartinib Garners Approval in Japan for Newly Diagnosed FLT3-ITD+ AML
FDA Approval Insights: Omidubicel in Blood Cancers Requiring Transplant
OncLive Honors 12 Cancer Care Pioneers
FDA Approval Insights: Zanubrutinib in CLL and SLL
Chinese Phase 3 Trial of Roxadustat in Non-Myeloid Malignancies Meets Primary End Point
Ivosidenib Wins European Approval for IDH1-mutated AML and Cholangiocarcinoma
Medicaid Expansion Improves Survival in Pancreatic, Gastric Cancers, Potentially Reducing Disparities
Telephone-Based Weight Loss Program Is Effective for Breast Cancer Survivors
Pembrolizumab Plus Chemo With or Without Bevacizumab Maintains OS Benefit in Frontline Cervical Cancer
Minimally Invasive Distal Pancreatectomy Provides Effective Alternative in Resectable Pancreatic Cancer